MUC1-C, which could facilitate the expression of IFNGR1 via inhibiting FBXW7 expression, drives dedifferentiation of castrate-resistant prostate cancer (CRPC) cell in a chromatin remodeling-dependent way (48). Here, IFNGR1 is linked to prostate carcinoma.